Kaveri Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.97 M
- Company Age 28 Year, 6 Months
- Last Filing with ROC 31 Mar 2015
- Satisfied Charges ₹ 1.00 M
- Revenue Growth -34.25%
- Profit Growth -204.55%
- Ebitda -18.97%
- Net Worth -13.01%
- Total Assets -3.23%
About Kaveri Drugs
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232MP1996PTC011086
- Company No.
011086
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Aug 1996
- Date of AGM
30 Sep 2015
- Date of Balance Sheet
31 Mar 2015
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Kaveri Drugs?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Saurabh Gupta ![]() | Director | 30-Sep-2005 | Current |
Pramod Gupta ![]() | Director | 06-Aug-1996 | Current |
Financial Performance of Kaveri Drugs.
Kaveri Drugs Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 34.25% decrease. The company also saw a substantial fall in profitability, with a 204.55% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.01%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kaveri Drugs?
In 2015, Kaveri Drugs had a promoter holding of 94.87% and a public holding of 5.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹1.00 M
Charges Breakdown by Lending Institutions
- The Cosmos Co-Operative Bank Ltd. : 0.10 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 May 2002 | The Cosmos Co-Operative Bank Ltd. | ₹1.00 M | Satisfied |
How Many Employees Work at Kaveri Drugs?
Unlock and access historical data on people associated with Kaveri Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Kaveri Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaveri Drugs's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.